Literature DB >> 21838978

Eliminating murine norovirus by cross-fostering.

Laurence U Buxbaum1, Pierina C DeRitis, Niansheng Chu, Pierre A Conti.   

Abstract

Murine norovirus (MNV) is a newly discovered and extremely prevalent pathogen of laboratory mouse colonies. MNV causes severe disease in some immunocompromised mouse strains and can cause persistent infections even in immunocompetent mice. Despite the fact that immunocompetent mice are generally asymptomatic, the possibility that MNV infection might alter immune responses makes its eradication a potentially useful goal for many facilities. Initial attempts by others to use a strategy of testing and culling were unsuccessful, whereas complete depopulation and facility decontamination was successful. However, these measures may be impractical, and finding less drastic approaches seemed prudent. Based on a report that cross-fostering of pups from MNV-positive mothers to MNV-negative ones could be successful in experimental MNV infection, we undertook a comprehensive fostering program using Swiss Webster mothers, careful sanitary measures, and fecal PCR testing to eradicate the virus from a mouse colony recently infected with MNV. We successfully decontaminated 17 of 18 (94%) litters and managed to prevent spread when a new MNV-infected mouse strain entered quarantine at our facility. These results suggest that cross-fostering, when performed in a setting of excellent sanitary procedures, may be practical for the large number of mouse facilities in which MNV is endemic. Copyright 2011 by the American Association for Laboratory Animal Science

Entities:  

Mesh:

Year:  2011        PMID: 21838978      PMCID: PMC3148639     

Source DB:  PubMed          Journal:  J Am Assoc Lab Anim Sci        ISSN: 1559-6109            Impact factor:   1.232


  12 in total

1.  STAT1-dependent innate immunity to a Norwalk-like virus.

Authors:  Stephanie M Karst; Christiane E Wobus; Margarita Lay; John Davidson; Herbert W Virgin
Journal:  Science       Date:  2003-03-07       Impact factor: 47.728

2.  Pathology of immunodeficient mice with naturally occurring murine norovirus infection.

Authors:  Jerrold M Ward; Christiane E Wobus; Larissa B Thackray; Cindy R Erexson; Larry J Faucette; Gaël Belliot; Elyssa L Barron; Stanislav V Sosnovtsev; Kim Y Green
Journal:  Toxicol Pathol       Date:  2006       Impact factor: 1.902

3.  Prevention of murine norovirus infection in neonatal mice by fostering.

Authors:  Susan R Compton
Journal:  J Am Assoc Lab Anim Sci       Date:  2008-05       Impact factor: 1.232

4.  Murine norovirus: an intercurrent variable in a mouse model of bacteria-induced inflammatory bowel disease.

Authors:  Karen Chase Lencioni; Audrey Seamons; Piper M Treuting; Lillian Maggio-Price; Thea Brabb
Journal:  Comp Med       Date:  2008-12       Impact factor: 0.982

Review 5.  Murine norovirus, a recently discovered and highly prevalent viral agent of mice.

Authors:  Kenneth S Henderson
Journal:  Lab Anim (NY)       Date:  2008-07       Impact factor: 12.625

6.  Murine norovirus infection has no significant effect on adaptive immunity to vaccinia virus or influenza A virus.

Authors:  Scott E Hensley; Amelia K Pinto; Heather D Hickman; Robin J Kastenmayer; Jack R Bennink; Herbert W Virgin; Jonathan W Yewdell
Journal:  J Virol       Date:  2009-04-29       Impact factor: 5.103

7.  Eradication of murine norovirus from a mouse barrier facility.

Authors:  Robin J Kastenmayer; Kathy A Perdue; William R Elkins
Journal:  J Am Assoc Lab Anim Sci       Date:  2008-01       Impact factor: 1.232

8.  Investigation of the impact of the common animal facility contaminant murine norovirus on experimental murine cytomegalovirus infection.

Authors:  Carmen M Doom; Holly M Turula; Ann B Hill
Journal:  Virology       Date:  2009-08-03       Impact factor: 3.616

9.  Effects of acute and chronic murine norovirus infections on immune responses and recovery from Friend retrovirus infection.

Authors:  Christoph G Ammann; Ronald J Messer; Kimberly Varvel; Blair L Debuysscher; Rachel A Lacasse; Amelia K Pinto; Kim J Hasenkrug
Journal:  J Virol       Date:  2009-10-07       Impact factor: 5.103

10.  Contemporary prevalence of infectious agents in laboratory mice and rats.

Authors:  Kathleen R Pritchett-Corning; Janice Cosentino; Charles B Clifford
Journal:  Lab Anim       Date:  2008-11-17       Impact factor: 2.471

View more
  6 in total

1.  Metaphylactic Antibiotic Treatment to Prevent the Transmission of Corynebacterium bovis to Immunocompromised Mouse Offspring.

Authors:  Emily C Pearson; Umarani Pugazhenthi; Derek L Fong; Derek E Smith; Andrew G Nicklawsky; Lauren M Habenicht; Michael K Fink; Jori K Leszczynski; Michael J Schurr; Christopher A Manuel
Journal:  J Am Assoc Lab Anim Sci       Date:  2020-09-09       Impact factor: 1.232

2.  Cross-Foster Rederivation Compared with Antibiotic Administration in the Drinking Water to Eradicate Bordetella pseudohinzii.

Authors:  Sarah E Clark; Jeanette E Purcell; Xuan Bi; Jeffrey D Fortman
Journal:  J Am Assoc Lab Anim Sci       Date:  2017-01-01       Impact factor: 1.232

3.  Use of Neonatal Fostering To Remove Helicobacter spp. from Deer Mice (Peromyscus maniculatus).

Authors:  Kathleen R Pritchett-Corning; Harry E Peery; Janet P Crossland; Heather M Wyatt; Marilyne Stuart; Carmel E Mothersill
Journal:  J Am Assoc Lab Anim Sci       Date:  2015-07       Impact factor: 1.232

4.  Eliminating murine norovirus, Helicobacter hepaticus, and intestinal protozoa by embryo transfer for an entire mouse barrier facility.

Authors:  Hwan Kim; Junpil Bang; Seung Ho Baek; Jae-Hak Park
Journal:  Exp Anim       Date:  2021-08-30

5.  Early handling and repeated cross-fostering have opposite effect on mouse emotionality.

Authors:  Alessandra Luchetti; Diego Oddi; Valentina Lampis; Eleonora Centofante; Armando Felsani; Marco Battaglia; Francesca R D'Amato
Journal:  Front Behav Neurosci       Date:  2015-04-21       Impact factor: 3.558

6.  Norovirus Changes Susceptibility to Type 1 Diabetes by Altering Intestinal Microbiota and Immune Cell Functions.

Authors:  James A Pearson; Ningwen Tai; Dilrukshi K Ekanayake-Alper; Jian Peng; Youjia Hu; Karl Hager; Susan Compton; F Susan Wong; Peter C Smith; Li Wen
Journal:  Front Immunol       Date:  2019-11-12       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.